Cheaper Drugs Derailed
Access limited to less costly versions of ‘biosimilars’ for cancer, autoimmune disorders
By LINDA A. JOHNSON - AP Medical Writer
Published: July 16, 2019

TRENTON, N.J. — They were the drugs that were supposed to save the U.S. tens of billions of dollars. Called “biosimilars,” they are near-copies of complex...
Subscribe Today!